We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
4 hedge funds and large institutions have $4.51M invested in Plus Therapeutics in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 4 → 4 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0% less capital invested
Capital invested by funds: $4.53M → $4.51M (-$18.8K)
22% less call options, than puts
Call options by funds: $36K | Put options by funds: $46K
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
$36K
Puts
$46K
Net Calls
-$10K
Net Calls Change
+$11K
Top Buyers
| 1 |
BlackRock
New York
|
+$617K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$309K |
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$617K |
| 2 |
Goldman Sachs
New York
|
-$27K |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
-$21K |
